Neuroprotective Effect of Reduced Glutathione on Oxaliplatin-Based Chemotherapy in Advanced Colorectal Cancer: A Randomized, Double-Blind, Placebo-Controlled Trial

This publication has 17 references indexed in Scilit:

• Oxaliplatin
  Drugs, 2000
• Cisplatin‐Induced Apoptotic Cell Death in Mouse Hybrid Neurons Is Blocked by Antioxidants Through Suppression of Cisplatin‐Mediated Accumulation of p53 but Not of Fas/Fas Ligand
  Journal of Neurochemistry, 2000
• Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal Cancer
  Journal of Clinical Oncology, 2000
• Oxaliplatin clinical activity: a review
  Critical Reviews in Oncology/Hematology, 2000
• Oxaliplatin or Paclitaxel in Patients With Platinum-Pretreated Advanced Ovarian Cancer: A Randomized Phase II Study of the European Organization for Research and Treatment of Cancer Gynecology Group
  Journal of Clinical Oncology, 2000
• Oxaliplatin added to 5-fluorouracil-based therapy (5-FU ± FA) in the treatment of 5-FU-pretreated patients with advanced colorectal carcinoma (ACRC): Results from the European compassionate-use program
  Annals of Oncology, 1999
• Comparative Neurotoxicity of Oxaliplatin, Cisplatin, and Ormaplatin in a Wistar Rat Model,
  Toxicological Sciences, 1998
• Comparative Neurotoxicity of Oxaliplatin, Cisplatin, and Ormaplatin in a Wistar Rat Model
  Toxicological Sciences, 1998
• Phase II study of oxaliplatin in poor-prognosis non-small cell lung cancer (NSCLC)
  European Journal Of Cancer, 1998
• Influence of glutathione administration on the disposition of free and total platinum in patients after administration of cisplatin
  Cancer Chemotherapy and Pharmacology, 1992